MEXICO CITY (Reuters) – Johnson & Johnson’s Janssen unit has received the green light to carry out late stage trials for its coronavirus vaccine in Mexico, Foreign Minister Marcelo Ebrard on Tuesday. He said U.S. vaccine developer Novavax Inc earlier this month also presented health authorities with a request to conduct phase 3 testing in Mexico.
(Reporting by Ana Isabel Martinez and Drazen Jorgic; Editing by Frank Jack Daniel)
